1 result(s) for IRESSA
| PI Name | Protocol # | Title |
|---|---|---|
| Alan Sandler | IRB00007669 | An Open Label, Multi-center, IRESSA Clinical Access Program of Gefitinib 250 mg (IRESSA) for the Continued Treatment of Patients in the United States Who Are Currently Benefiting or Have Benefited from Gefitinib Treatment |
You may qualify for additional trials within our Phase 1 Program

